Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

In vivo amphetamine action is contingent on αCaMKII.

Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, Pollak DD, Gainetdinov RR, Sitte HH.

Neuropsychopharmacology. 2014 Oct;39(11):2681-93. doi: 10.1038/npp.2014.124. Epub 2014 May 29.

2.

Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.

Steinkellner T, Montgomery TR, Hofmaier T, Kudlacek O, Yang JW, Rickhag M, Jung G, Lubec G, Gether U, Freissmuth M, Sitte HH.

J Neurosci. 2015 May 27;35(21):8258-71. doi: 10.1523/JNEUROSCI.4034-14.2015. Erratum in: J Neurosci. 2015 Aug 19;35(33):11762.

3.

Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.

Steinkellner T, Yang JW, Montgomery TR, Chen WQ, Winkler MT, Sucic S, Lubec G, Freissmuth M, Elgersma Y, Sitte HH, Kudlacek O.

J Biol Chem. 2012 Aug 24;287(35):29627-35. doi: 10.1074/jbc.M112.367219. Epub 2012 Jul 9.

4.

Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.

Corvol JC, Valjent E, Pascoli V, Robin A, Stipanovich A, Luedtke RR, Belluscio L, Girault JA, Hervé D.

Neuropsychopharmacology. 2007 May;32(5):1109-21. Epub 2006 Oct 25.

5.

Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.

Rickhag M, Owens WA, Winkler MT, Strandfelt KN, Rathje M, Sørensen G, Andresen B, Madsen KL, Jørgensen TN, Wörtwein G, Woldbye DP, Sitte H, Daws LC, Gether U.

J Biol Chem. 2013 Sep 20;288(38):27534-44. doi: 10.1074/jbc.M112.441295. Epub 2013 Jul 24.

6.

Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine.

Loweth JA, Singer BF, Baker LK, Wilke G, Inamine H, Bubula N, Alexander JK, Carlezon WA Jr, Neve RL, Vezina P.

J Neurosci. 2010 Jan 20;30(3):939-49. doi: 10.1523/JNEUROSCI.4383-09.2010.

7.

Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U.

Neuron. 2006 Aug 17;51(4):417-29.

8.

Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.

O'Neill B, Tilley MR, Han DD, Thirtamara-Rajamani K, Hill ER, Bishop GA, Zhou FM, During MJ, Gu HH.

Neuropharmacology. 2014 Apr;79:626-33. doi: 10.1016/j.neuropharm.2013.12.023. Epub 2014 Jan 9.

9.

Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.

Spielewoy C, Biala G, Roubert C, Hamon M, Betancur C, Giros B.

Psychopharmacology (Berl). 2001 Dec;159(1):2-9. Epub 2001 Sep 11.

10.
11.

The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.

Pizzo AB, Karam CS, Zhang Y, Yano H, Freyberg RJ, Karam DS, Freyberg Z, Yamamoto A, McCabe BD, Javitch JA.

Mol Psychiatry. 2013 Jul;18(7):824-33. doi: 10.1038/mp.2012.82. Epub 2012 Jun 19.

12.

Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.

Wheeler DS, Underhill SM, Stolz DB, Murdoch GH, Thiels E, Romero G, Amara SG.

Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7138-47. doi: 10.1073/pnas.1511670112. Epub 2015 Nov 9.

13.

The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.

Cagniard B, Sotnikova TD, Gainetdinov RR, Zhuang X.

J Neurogenet. 2014 Mar-Jun;28(1-2):112-21. doi: 10.3109/01677063.2014.908191.

PMID:
24673634
14.
15.
16.

Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A.

J Neurosci. 2010 Aug 18;30(33):11043-56. doi: 10.1523/JNEUROSCI.1682-10.2010.

17.

Short post-weaning social isolation induces long-term changes in the dopaminergic system and increases susceptibility to psychostimulants in female rats.

Lampert C, Arcego DM, de Sá Couto-Pereira N, Dos Santos Vieira A, Toniazzo AP, Krolow R, Garcia E, Vendite DA, Calcagnotto ME, Dalmaz C.

Int J Dev Neurosci. 2017 Oct;61:21-30. doi: 10.1016/j.ijdevneu.2017.05.003. Epub 2017 May 27.

PMID:
28559209
18.

Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion.

Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S.

Neuropsychopharmacology. 2004 Jan;29(1):72-80.

20.

Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.

Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A.

PLoS Biol. 2007 Oct 16;5(10):e274.

Supplemental Content

Support Center